The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bansal-Pakala, P.
Right arrow Articles by Croft, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bansal-Pakala, P.
Right arrow Articles by Croft, M.
The Journal of Immunology, 2002, 169: 5005-5009.
Copyright © 2002 by The American Association of Immunologists

Defective T Cell Priming Associated with Aging Can Be Rescued by Signaling Through 4-1BB (CD137)1

Pratima Bansal-Pakala and Michael Croft2

Division of Immunochemistry, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121

Aging is associated with an increased susceptibility to infectious agents and correlates with a decreased ability to mount an immune response. It has been postulated that the major defect is related to a reduced capacity of an aged T cell to proliferate and to survive after encounter with Ag. This is similar to the phenotype associated with T cell tolerance in young adults. In this study, we determined whether targeting 4-1BB (CD137), a member of the TNFR family implicated in providing expansion and survival signals to T cells, can rescue defective priming in aged and tolerized animals. Agonist Abs to 4-1BB injected in vivo were capable of preventing CD4 T cell tolerance to soluble peptide in young mice. Moreover, anti-4-1BB rescued defective priming of aged TCR transgenic CD4 T cells responding to peptide Ag in a young host, and as importantly, anti-4-1BB completely restored T cell priming to protein Ag in nontransgenic aged mice. These studies demonstrate that 4-1BB, and potentially other costimulatory members of the TNFR family, are targets for therapies aimed at augmenting weak T cell responses in elderly immunocompromised individuals.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. E. Ruby and A. D. Weinberg
OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age
J. Immunol., February 1, 2009; 182(3): 1481 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Dominguez and J. Lustgarten
Implications of Aging and Self-Tolerance on the Generation of Immune and Antitumor Immune Responses
Cancer Res., July 1, 2008; 68(13): 5423 - 5431.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Zhu, G. Zhu, L. Luo, A. S. Flies, and L. Chen
CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype
Blood, June 1, 2007; 109(11): 4882 - 4889.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Bukczynski, T. Wen, C. Wang, N. Christie, J.-P. Routy, M.-R. Boulassel, C. M. Kovacs, K. S. MacDonald, M. Ostrowski, R.-P. Sekaly, et al.
Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L
J. Immunol., November 15, 2005; 175(10): 6378 - 6389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-W. Lee, A. T. Vella, B. S. Kwon, and M. Croft
Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB
J. Immunol., June 1, 2005; 174(11): 6803 - 6808.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Shimizu, R. Iida, Y. Sato, E. Moriizumi, A. Nishikawa, and Y. Ishida
Cross-Linking of CD45 on Suppressive/Regulatory T Cells Leads to the Abrogation of Their Suppressive Activity In Vitro
J. Immunol., April 1, 2005; 174(7): 4090 - 4097.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Norian and P. M. Allen
No Intrinsic Deficiencies in CD8+ T Cell-Mediated Antitumor Immunity with Aging
J. Immunol., July 15, 2004; 173(2): 835 - 844.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Lathrop, C. A. Huddleston, P. A. Dullforce, M. J. Montfort, A. D. Weinberg, and D. C. Parker
A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions
J. Immunol., June 1, 2004; 172(11): 6735 - 6743.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.